News
ACG Invests in Mumbai-Based start-up contract research organization IQGEN-X
Supplier of integrated pharmaceutical manufacturing solutions, ACG, has revealed in a Nov. 3, 2020 press release, that it has acquired a significant stake in IQGEN-X, a Mumbai-based start-up contract research organization (CRO).
The investment supports ACG’s augmentation into R&D and...
News
Turkish Cargo strengthens its presence in Budapest with Scheduled Cargo Flights
Enjoying the widest direct cargo flight network in the world, the global air cargo carrier, Turkish Cargo continues to increase the number of direct freighter only destinations.
Having an attractive location from the viewpoint of the logistics and trading companies,...
News
Pelican BioThermal to Present at LogiPharma Europe
Pelican BioThermal, the global name in temperature controlled packaging, will be attending this year’s virtual LogiPharma Europe event and highlight how products have been adapted to meet the rising requirements of the pharmaceutical sector’s rapid response to the global...
News
The Pistoia Alliance warns pharma needs better data-sharing infrastructure, following roundtable with Gilead, Roche and others
The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D, held a virtual roundtable with leaders from global pharma organizations, including Gilead, Roche and AbbVie, to discuss learnings to...
Clinical Trials
Phesi analysis shows difference of up to three months in current COVID-19 vaccine trial recruitment
Analysis from virtual clinical development specialist Phesi shows the enrollment and effectiveness of two current COVID-19 vaccine trials conducted by global pharmaceutical development companies. On the surface, both trials appear to be on track to complete enrollment, however, looking...
News
RDIF and Uniao Quimica file documents for registration of Sputnik V vaccine with regulator in Brazil
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União Química Farmacêutica Nacional and the Government of the State of Paraná announce the pre-submission of preliminary documents to Brazil's National Health Surveillance Agency (ANVISA), in order to register...
Clinical Trials
Tiziana begins study of nasally administered Foralumab either alone or in combo with dexamethasone to treat COVID-19 in Brazil
Tiziana Life Sciences, a biotechnology company, announced initiation of a collaborative clinical study investigating nasally administered Foralumab either alone or in combination with orally administered dexamethasone in COVID-19 patients in Brazil. In view of the importance and urgency, scientific...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















